Predictors of CD4 cell recovery following initiation of antiretroviral therapy among HIV‐1 positive patients with well‐estimated dates of seroconversion

By  

HIV MEDICINE, Vol. 19, Iss. 3, 2018-03 ,pp. : 184-194

John Wiley & Sons Inc

Access to resources Recommend Favorite

Time to eligibility for antiretroviral therapy in adults with CD4 cell count 

By  

HIV MEDICINE, Vol. 16, Iss. 8, 2015-09 ,pp. : 512-518

John Wiley & Sons Inc

Access to resources Recommend Favorite

Biomarkers of Progression after HIV Acute/Early Infection: Nothing Compares to CD4⁺ T-cell Count?

By Turk Gabriela   Ghiglione Yanina   Hormanstorfer Macarena   Laufer Natalia   Coloccini Romina   Salido Jimena   Trifone César   Ruiz María Julia   Falivene Juliana   Holgado María Pía   Caruso María Paula   Figueroa María Inés   Salomón Horacio   Giavedoni Luis D.   Pando María de los Ángeles   Gherardi María Magdalena   Rabinovich Roberto Daniel   Pury Pedro A.   Sued Omar  

Viruses, Vol. 10, Iss. 1, 2018-01 ,pp. : 34-34

MDPI

Access to resources Recommend Favorite

T cell apoptosis in HIV-infected patients with incomplete immune recovery after antiretroviral therapy

By Saidakova E.   Korolevskaya L.   Shmagel N.   Shmagel K.   Chereshnev V.  

Doklady Biological Sciences, Vol. 450, Iss. 1, 2013-05 ,pp. : 189-191

MAIK Nauka/Interperiodica

Access to resources Recommend Favorite

Declines in highly active antiretroviral therapy initiation at CD4 cell counts ≤ 200 cells/μL and the contribution of diagnosis of HIV at CD4 cell counts ≤ 200 cells/μL in British Columbia, Canada

By  

HIV MEDICINE, Vol. 16, Iss. 6, 2015-07 ,pp. : 337-345

John Wiley & Sons Inc

Access to resources Recommend Favorite